Found: 6
Select item for more details and to access through your institution.
Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091760
- By:
- Publication type:
- Article
ASO Visual Abstract: Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection—A Multicenter Study of 1753 Patients
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 346, doi. 10.1245/s10434-022-12529-6
- By:
- Publication type:
- Article
Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma.
- Published in:
- Advanced Science, 2024, v. 11, n. 9, p. 1, doi. 10.1002/advs.202305508
- By:
- Publication type:
- Article
Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma (Adv. Sci. 9/2024).
- Published in:
- Advanced Science, 2024, v. 11, n. 9, p. 1, doi. 10.1002/advs.202470054
- By:
- Publication type:
- Article
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.
- Published in:
- Cancer Science, 2024, v. 115, n. 7, p. 2159, doi. 10.1111/cas.16194
- By:
- Publication type:
- Article